919.865.2810
cagoranos@wyrick.com
Chris is a member of the firm’s Capital Markets practice group. His practice focuses on assisting clients on a wide range of issues including corporate governance, securities offerings, mergers and other strategic combinations, as well as reporting requirements.
Chris earned his J.D. from the University of North Carolina School of Law. He also holds a B.S. in Economics from Florida State University and an M.Div., magna cum laude, from Duke University Divinity School.
- Board Member, Religious Coalition for a Nonviolent Durham
- Represented a Nasdaq-listed clinical stage pharmaceutical company in a registered direct and concurrent private placement totaling approximately $18 million.
- Represented a NYSE-listed bank holding company in a $100 million preferred stock offering.
- Represented a Nasdaq-listed clinical stage pharmaceutical company in a public offering totaling approximately $9.0 million.
- SEC No-Action Letter Offers Path to Increased Voting Among Retail Shareholders
- Enhanced Accommodations for Issuers Submitting Draft Registration Statements
- EDGAR Next: Questions and Answers
- SEC Charges Four Companies with Misleading Cyber Disclosures
- SEC Adopts Landmark Climate-Related Disclosure Rules
- SEC Adopts Final Rules Relating to SPACs, Shell Companies, and De-SPAC Transactions
- Tracking the SEC’s Climate and ESG Task Force and its Enforcement Actions
- The U.S. Bureau of Economic Analysis Benchmark Survey
